# Guizhou Yinuoqini Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guizhou-yinuoqini-technology

- Industry: Pharmaceuticals
- Headquarters: China
- Latest round: Series A (Dec 10, 2021)
- Investors on record: 2

## About

Established in 2018 and based in Guizhou, China, Guizhou Yinuoqini Technology is a medical health company that focus on research and development of targeted drug.

The company main business is research, development, production and application of targeted small molecule drugs.

The company plan to use the series A funding for phase I clinical trial study of core product LRRK2 (Leucine-rich repeat kinase 2) inhibitor WXWH0226 and R&D team building.

## Funding rounds

- Series A, Dec 10, 2021 — Richlink Capital, Shenzhen Qianhai Zhenxin Asset Management

## Investors

- Richlink Capital (https://capitalatlas.ai/funds/richlink-capital) — Series A
- Shenzhen Qianhai Zhenxin Asset Management — Series A